HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Huidong Yu Selected Research

Huidong Yu Research Topics

Disease

5Neoplasms (Cancer)
10/2018 - 04/2013
1Cardiotoxicity
12/2018
1Inflammation (Inflammations)
10/2018
1Neurodegenerative Diseases (Neurodegenerative Disease)
12/2015
1Neuroblastoma
09/2014
1Ischemia
06/2013
1Breast Neoplasms (Breast Cancer)
06/2013
1Cerebral Hemorrhage
06/2013
1Hypertension (High Blood Pressure)
06/2013
1Kidney Neoplasms (Kidney Cancer)
06/2013
1Lung Neoplasms (Lung Cancer)
06/2013
1Stroke (Strokes)
06/2013
1Ovarian Neoplasms (Ovarian Cancer)
04/2013
1Colonic Neoplasms (Colon Cancer)
04/2013

Drug/Important Bio-Agent (IBA)

1ShK neurotoxinIBA
12/2018
1CamptothecinIBA
10/2018
1Pharmaceutical PreparationsIBA
10/2018
1CrizotinibIBA
11/2017
1Anaplastic Lymphoma KinaseIBA
11/2017
1ceritinibIBA
11/2017
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
11/2016
1Neuroprotective AgentsIBA
12/2015
1geranylgeranyltransferase type-I (protein geranylgeranyltransferase)IBA
02/2015
1ras ProteinsIBA
02/2015
1Farnesyltranstransferase (Farnesyltransferase)IBA
02/2015
1acetamideIBA
09/2014
1Protein Kinase InhibitorsIBA
09/2014
11-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA
09/2014
1Atorvastatin (Lipitor)FDA Link
06/2013
1EnzymesIBA
06/2013
1Phosphotransferases (Kinase)IBA
06/2013
1Irinotecan (Camptosar)FDA LinkGeneric
04/2013
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
04/2013
1Topotecan (Hycamtin)FDA LinkGeneric
04/2013